DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE

Abstract: the present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with a serotonin 5-htreceptor.

Inventor(s): Alex Nivorozhkin, Michael Palfreyman

CPC Classification: C07D209/16 (HETEROCYCLIC COMPOUNDS (macromolecular compounds ))

Search for rejections for patent application number 20250154101